Surrozen (SRZN)

• Market cap: $188M
• 1 day: 0.55%
• 5 days: -4.12%
• 1 month: 35.79%
• 3 months: 69.82%
• 6 months: 144.85%
• Year to date: 53.61%
• 1 year: 62.63%
• 5 years: -85.57%
• 10 years: -85.57%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41